Issue #220
- Merck Protease Inhibitor MK-639 -- Trial Cities Announced
- Infected Infant Appears to Clear HIV
- 3TC and Protease Inhibitors: Citizen's Petition Asks Faster Approval
- Topotecan Now Available for HIV, PML Research
- 3TC: Expanded Access Will Be Limited
- FDA Reform in Congress: AIDS Community Absent
- National AIDS Treatment Information Project
- ICC Trials -- Enrollment Problem
- Proposal: Monitoring Program for Early Rapid Testing of New AIDS Treatments
source: AIDS Treatment News
